Transculturalization of a diabetes-specific nutrition algorithm: Asian application

Current Diabetes Reports

Volumn 12, Issue 2, 2012, Pages 213-219

  Su, Hsiu Yueh ^a,b,e   Tsang, Man Wo ^c   Huang, Shih Yi ^b   Mechanick, Jeffrey I ^d   Sheu, Wayne H H ^e,f,g   Marchetti, Albert ^h  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^h UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Asians; Diabetes; Diabetes specific formula; Medical nutrition therapy

Indexed keywords

HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ALGORITHM; ARTICLE; ASIAN; BARIATRIC SURGERY; BODY COMPOSITION; CALORIC INTAKE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CULTURAL FACTOR; DIABETES MELLITUS; DISEASE COURSE; DISEASE MANAGEMENT; DYSLIPIDEMIA; EATING HABIT; ETHNICITY; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; HYPERTENSION; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; MEDICAL NUTRITION THERAPY; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREVALENCE; PROTEIN INTAKE; RISK FACTOR; SOCIOECONOMICS; SODIUM RESTRICTION; TRANSCULTURALIZATION; URBANIZATION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ALGORITHMS; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FEMALE; GUIDELINES AS TOPIC; HUMANS; LIFE STYLE; MALE; NUTRITION THERAPY; OBESITY; PREDIABETIC STATE;

EID: 84862776812     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0252-0     Document Type: Article

References (53)

1. Chang CH, Shau WY, Jiang YD, Li HY, Chang TJ, Sheu WH, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med. 2010;27:636-43.
2. International Diabetes Federation. IDF Diabetes Atlas. 2009. http://www.idf.org/diabetesatlas/. Accessed October 10 2011.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53. (Pubitemid 38579764)
4. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-40.
5. YoonKH, Lee JH, KimJW, Cho JH, ChoiYH,KoSH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681-8. (Pubitemid 46048556)
6. Wang JS, Tu ST, Lee IT, Lin SD, Lin SY, Su SL, et al. Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring. Diabetes Metab Res Rev. 2011;27:79-84.
7. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519-27. (Pubitemid 34517197)
8. Chiang SC, Lee JK, Chen CH, Chuang LM, Tsan KW, Sheu WH, et al. Justifying the high prevalence of microalbuminuria for type 2 diabetic patients in Taiwan with conditional probability approach- a DEMAND II study. J Chin Med Assoc. 2011;74:3-10.
9. Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia. 2005;48:17-26. (Pubitemid 40174652)
10. Scalzitti DA. Evidence-based guidelines: application to clinical practice. Phys Ther. 2001;81:1622-8. (Pubitemid 32947539)
11. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527-30. (Pubitemid 29189000)
12. Feder G, Eccles M, Grol R, Griffiths C, Grimshaw J. Clinical guidelines: using clinical guidelines. BMJ. 1999;318:728-30. (Pubitemid 29192002)
13. Problems with Current Practice Guidelines and Quality Improvement (QI) Programs and How to Solve Them. http://wellness.wikispaces.com/page/pdf/ Problems+with+Current+ Practice+Guidelines+and+Quality+Improvement+%28QI% 29+Programs+and+How+to+Solve+Them. Accessed November 9 2011.
14. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-63.
15. International Diabetes Institute. The Asia-Pacific perspective: Redefining obesity and its treatment. 2000. http://www.diabetes. com.au/pdf/obesity-report.pdf. Accessed November 9 2011.
16. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182-6. (Pubitemid 38579787)
17. Examination Committee of Criteria for 'Obesity Disease' in Japan. Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J. 2002;66:987-92.
18. Diabetes Association of the Republic of China. Diabetes Clinical Practice Guideline. 2010. http://www.endo-dm.org.tw/dia/dia- bookidx.asp Accessed October 10 2011.
19. Chinese Diabetes Society. China medical nutrition therapy guideline for diabetes. 2010. http://cdschina.org/. Accessed October 10 2011.
20. Malaysian Endocrine & Metabolic Society, Ministry of Health (Malaysia), Academy of Medicine Malaysia, Persatuan Diabetes Malaysia. Management of Type 2 Diabetes Mellitus. 2009. http://www.scribd.com/doc/ 18473103/Management-of-Type-2-Diabetes- Mellitus-4th-Edition-2009. Accessed October 10 2011.
21. DiabetesIndia.com. The Management of Type 2 Diabetes: Academic Care to Clinical Guidelines 2009. 2009. http://www. diabetesindia.com/diabetes/site- consensus.htm. Accessed October 10 2011.
22. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783-9. (Pubitemid 351697954)
23. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31 Suppl 1:S61-78.
24. Astrup A, Dyerberg J, Selleck M, Stender S. Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obes Rev. 2008;9 Suppl 1:48-52. (Pubitemid 351643190)
25. Kim S, Moon S, Popkin BM. The nutrition transition in South Korea. Am J Clin Nutr. 2000;71:44-53. (Pubitemid 30033583)
26. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev. 1997;55:31-43. (Pubitemid 27220092)
27. Popkin BM. The nutrition transition and its health implications in lower-income countries. Public Health Nutr. 1998;1:5-21. (Pubitemid 128549109)
28. Jenkins DJ,Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34:362-6. (Pubitemid 11159124)
29. Chan EM, Cheng WM, Tiu SC, Wong LL. Postprandial glucose response to Chinese foods in patients with type 2 diabetes. J Am Diet Assoc. 2004;104:1854-8. (Pubitemid 39572873)
30. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 2002;25:608-13.
31. Morris SF, Wylie-Rosett J. Medical nutrition therapy: a key to diabetes management and prevention. Clinical Diabetes. 2010;28:12-8.
32. Lang HF, Chou CY, Sheu WH, Lin JY. Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m(2). Nutr Res. 2011;31:378-86.
33. Liang KW, Lee WJ, Lee IT, Lee WL, Lin SY, Hsu SL, et al. Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome. Clin Chim Acta. 2011;412:1835-41.
34. Sheu WH, Chang TM, Lee WJ, Ou HC, Wu CM, Tseng LN, et al. Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity (Silver Spring). 2008;16:1033-8. (Pubitemid 351620479)
35. American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement by the American Diabetes Association. Diabetes Care. 2007;30 Suppl 1:S48-65.
36. Department of Health Professional Development and Quality Assurance Clinical Audit and Guideline Working Group. Type II diabetes treatment guidelines. 2010. http://www.pdqa.gov.hk/tc-chi/primarycare/clinical/files/DM3. pdf. Accessed October 10 2011.
37. Huang MC, Hsu CC, Wang HS, Shin SJ. Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. Diabetes Care. 2010;33:233-9.
38. Pohl M, Mayr P, Mertl-Roetzer M, Lauster F, Lerch M, Eriksen J, et al. Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr. 2005;59:1221-32. (Pubitemid 41655626)
39. Lansink M, van Laere KM, Vendrig L, Rutten GE. Lower postprandial glucose responses at baseline and after 4 weeks use of a diabetes-specific formula in diabetes type 2 patients. Diabetes Res Clin Pract. 2011;93:421-9.
40. Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005;28:2267-79. (Pubitemid 41242484)
41. Suchy FJ, Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB, et al. National Institutes of Health Consensus Development Conference: lactose intolerance and health. Ann Intern Med. 2010;152:792-6.
42. Shaukat A, Levitt MD, Taylor BC, MacDonald R, Shamliyan TA, Kane RL, et al. Systematic review: effective management strategies for lactose intolerance. Ann Intern Med. 2010;152:797-803.
43. Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 2011;28:628-42.
44. Lakdawala M, Bhasker A. Asian Consensus Meeting on Metabolic Surgery (ACMOMS). Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg. 2010;20:929-36.
45. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11-9. (Pubitemid 38293521)
46. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-23. (Pubitemid 40138015)
47. Chiang CE, Wang TD, Li YH, Lin TH, Chien KL, Yeh HI, et al. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension. J Formos Med Assoc. 2010;109:740-73.
48. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-24.
49. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878-84. (Pubitemid 37413724)
50. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1-290.
51. Chan JC, Chan SP, Deerochanawong C, Go RT, Lee KO, Ma RC, et al. Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: What we know and don't know. Diabetes Res Clin Pract. 2011;94:1-13.
52. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. 2007. http://www.kidney.org/professionals/KDOQI/guideline-diabetes/. Accessed October 10 2011.
53. Park JE, Chiang CE, Munawar M, Pham GK, Sukonthasarn A, Aquino AR, et al. Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey. Eur J Cardiovasc Prev Rehabil. 2011.